| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | CHEMOURS COMPANY | Jan 10, 2024 | |
| Buy | Chemours Company | Aug 9, 2023 | |
| Buy | Chemours Company | Jul 6, 2023 | |
| Sell | Chemours Company | Jul 6, 2023 | |
| Buy | CHEMOURS COMPANY | Nov 3, 2022 | |
| Sell | The Chemours Co. | Feb 8, 2021 | |
| Sell | CHEMOURS CO. CMN | Mar 5, 2020 | |
| Sell | CC CMN | Oct 25, 2018 | |
| Sell | CC | Oct 10, 2017 | |
| Sell | Chemours Company | Oct 1, 2015 |
This page tracks congressional stock trading activity in The Chemours Company (CC) in the Basic Materials sector. Disclosed Capitol has indexed 13 disclosed congressional trades involving CC. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of February 2024 — Disclosed Capitol has tracked 13 disclosed congressional trades in The Chemours Company (CC) — 6:2 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jan 10, 2024 | Ro Khanna | D | Exchange | $1,001 - $15,000 |
| Aug 9, 2023 | Michael C. Burgess | R | Buy | $15,001 - $50,000 |
| Jul 6, 2023 | Michael C. Burgess | R | Buy | $15,001 - $50,000 |
| Jul 6, 2023 | Michael C. Burgess | R | Sale | $1,001 - $15,000 |
| Nov 3, 2022 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Feb 8, 2021 | Janet L. Yellen | Sale | $1,001 - $15,000 | |
| Mar 5, 2020 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Oct 25, 2018 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Oct 10, 2017 | Tammy Duckworth | D | Sale | $1,001 - $15,000 |
| Oct 1, 2015 | Richard L. Hanna | R | Sale | $1,001 - $15,000 |
Across the 13 disclosed congressional trades in The Chemours Company (CC), members of Congress have reported 2 buys and 6 sells. The average 30-day alpha vs. the S&P 500 is -13.34%.
As of August 2026, corporate insiders at The Chemours Company have filed 13 SEC Form 4 transactions in CC over the past 12 months — including 7 open-market buys worth $489K.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-08-12 | Will David — Chief Accounting Officer | Tax Withholding | $37K |
| 2026-08-12 | Familiar Calderon Gerardo — See Remarks | Purchase | $30K |
| 2026-08-11 | Dignam Denise — Chief Executive Officer | Purchase | $51K |
| 2026-08-07 | Cowan Alister — Director | Purchase | $203K |
| 2026-08-07 | Foley Michael Robert — See Remarks | Purchase | $30K |
| 2026-08-07 | Martinko Joseph T. — See Remarks | Purchase | $30K |
| 2026-08-07 | CRANSTON MARY B — Director | Purchase | $95K |
| 2026-08-06 | HOSTETTER SHANE — Chief Financial Officer | Purchase | $50K |
| 2026-08-06 | HOSTETTER SHANE — Chief Financial Officer | Tax Withholding | $47K |
| 2026-08-01 | Familiar Calderon Gerardo — See Remarks | Tax Withholding | $16K |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
As of May 2025, The Chemours Company has 1 federal contract award record on file from USAspending.gov — most recently $4.1M from the Department of Defense on 2025-05-27.
| Award date | Agency | Amount |
|---|---|---|
| 2025-05-27 | Department of Defense · Defense Logistics Agency | $4.1M |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, The Chemours Company reported revenue of $6.03B and net income of -$238.0M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $1.59B, net income -$274.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.